This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Kristen Hopson, Ph.D.
Vice President of Preclinical Discovery and Develo at Generate Biomedicines


Kristen Hopson is vice president of preclinical discovery and development at Generate Biomedicines, leading a team of innovative and passionate scientists to drive the research and development of products across multiple modalities and therapeutic areas.

Kristen joined Generate from Moderna Therapeutics, where she led preclinical cancer vaccine research and played a key role in taking the personalized cancer vaccine program from preclinical development into Phase 2 clinical development. Kristen also led the translational oncology team at Moderna, driving biomarker development and execution across all oncology clinical trials at the company. She has previous experience in translational medicine and vaccine development in the context of T-cell vaccines targeting various oncology, viral, and bacterial targets.

Kristen received a PhD in molecular medicine from Boston University School of Medicine and completed her postdoctoral training at Harvard Medical School/MGH and Pfizer. Kristen holds two B.S.s, in biochemistry, cell and molecular biology and in zoology, from Connecticut College.

Agenda Sessions

  • The Application of Generative Biology to Accelerate Therapeutics for Treating Immune Mediated Diseases